Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. MU
6. USO
7. APGE
8. ABBV
9. DFTX
10. NAVN

Go back to Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026
Compugen Ltd (NASDAQ: CGEN) Delayed: 2.07 --0 (-0%)
Previous Close $2.07    52 Week High $7.79 
Open $2.07    52 Week Low $4.32 
Day High $2.07    P/E N/A 
Day Low $2.07    EPS $-0.36 
Volume 3       

Compugen Ltd (NASDAQ: CGEN) Delayed: 2.07 --0 (-0%)
Previous Close $2.07    52 Week High $7.79 
Open $2.07    52 Week Low $4.32 
Day High $2.07    P/E N/A 
Day Low $2.07    EPS $-0.36 
Volume 3